The findings may set the stage for defibrotide clinical trials in potentially several diseases.

Researchers say it’s a sign that more targeted therapies are needed for the vulnerable patient population.

Although osteoarthritis has no cure, researchers are developing a new intervention to improve patients’ chronic pain outcomes.

The finding will indicate how aggressively physicians should treat patients with the associated condition.

The finding will likely help physicians develop targeted therapies for future COVID patients.

Researchers say the support program could be extended to many patient populations.